Your browser doesn't support javascript.
loading
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial.
Pyne, Sarah; Sach, Tracey H; Lawrence, Megan; Renz, Susanne; Eminton, Zina; Stuart, Beth; Thomas, Kim S; Francis, Nick; Soulsby, Irene; Thomas, Karen; Permyakova, Natalia V; Ridd, Matthew J; Little, Paul; Muller, Ingrid; Nuttall, Jacqui; Griffiths, Gareth; Layton, Alison M; Santer, Miriam.
Affiliation
  • Pyne S; Health Economics Group, Norwich Medical School, University of East Anglia, Norwich, Norfolk, UK.
  • Sach TH; Health Economics Group, Norwich Medical School, University of East Anglia, Norwich, Norfolk, UK t.sach@soton.ac.uk.
  • Lawrence M; Primary Care Research Centre, School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, UK.
  • Renz S; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Eminton Z; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Stuart B; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Thomas KS; Primary Care Research Centre, School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, UK.
  • Francis N; Centre for Evaluation and Methods Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
  • Soulsby I; Centre for Evidence Based Dermatology, University of Nottingham, Nottingham, UK.
  • Thomas K; Primary Care Research Centre, School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, UK.
  • Permyakova NV; Public Contributor, Primary Care Research Centre, University of Southampton, Southampton, Hampshire, UK.
  • Ridd MJ; Public Contributor, Primary Care Research Centre, University of Southampton, Southampton, Hampshire, UK.
  • Little P; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Muller I; Population Health Sciences, University of Bristol, Bristol, Bristol, UK.
  • Nuttall J; Primary Care Research Centre, School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, UK.
  • Griffiths G; Primary Care Research Centre, School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, UK.
  • Layton AM; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Santer M; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
BMJ Open ; 13(12): e073245, 2023 12 11.
Article in En | MEDLINE | ID: mdl-38081673
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Spironolactone / Acne Vulgaris Limits: Adult / Female / Humans Language: En Journal: BMJ Open Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Spironolactone / Acne Vulgaris Limits: Adult / Female / Humans Language: En Journal: BMJ Open Year: 2023 Document type: Article